BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/31/2026 8:57:03 AM | Browse: 21 | Download: 3
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Incretin-based therapies in hepatology practice
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Merve Eren Durmus, Gokhan Koker and Serkan Ocal |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gokhan Koker, Associate Professor, Lecturer, MD, Department of Internal Medicine, University of Health Sciences, Antalya Training and Research Hospital, Varlik St. Antalya Training and Research Hospital, Antalya 07100, Türkiye. gokhan.koker@sbu.edu.tr |
| Key Words |
Glucagon-like peptide-1 receptor agonists; Tirzepatide; Dual incretin therapy; Metabolic dysfunction-associated steatotic liver disease; Metabolic dysfunction-associated steatohepatitis; Steatotic liver disease; Liver fibrosis; Hepatocellular carcinoma; Frailty; Resmetirom |
| Core Tip |
Incretin-based therapies matter to hepatology because they act on the metabolic drivers of steatotic liver disease. Their hepatic benefit has to be judged by fibrosis-oriented monitoring rather than by the scale. Histological and real-world data are encouraging, but we still do not know whether these drugs prevent decompensation, hepatocellular carcinoma, transplantation or liver-related death. They are best regarded as partners to liver-directed therapy, not as replacements for standard cirrhosis care and surveillance. |
| Citation |
Durmuş ME, Köker G, Öcal S. Incretin-based therapies in hepatology practice. World J Hepatol 2026; In press
|
| PDF |
125275-in-press.pdf
|
 |
Received |
|
2026-07-07 09:08 |
 |
Peer-Review Started |
|
2026-07-07 09:09 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2026-07-23 05:31 |
 |
Revised |
|
2026-07-31 20:41 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-08-31 03:15 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-08-31 08:57 |
 |
Articles in Press |
|
2026-08-31 08:57 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.